Real life use of vasopressin in patients with cardiogenic shock: a retrospective cohort analysis
Crit Care
.
2023 Jul 19;27(1):291.
doi: 10.1186/s13054-023-04574-8.
Authors
Maxime Nguyen
1
2
3
4
,
Vivien Berthoud
5
,
Alexis Rizk
5
,
Bélaïd Bouhemad
5
6
7
8
,
Pierre-Grégoire Guinot
5
6
7
8
Affiliations
1
Department of Anesthesiology and Intensive Care, Dijon University Hospital, 21000, Dijon, France. maxime.nguyensoenen@gmail.com.
2
University of Burgundy and Franche-Comté, LNC UMR1231, 21000, Dijon, France. maxime.nguyensoenen@gmail.com.
3
INSERM, LNC UMR1231, 21000, Dijon, France. maxime.nguyensoenen@gmail.com.
4
FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000, Dijon, France. maxime.nguyensoenen@gmail.com.
5
Department of Anesthesiology and Intensive Care, Dijon University Hospital, 21000, Dijon, France.
6
University of Burgundy and Franche-Comté, LNC UMR1231, 21000, Dijon, France.
7
INSERM, LNC UMR1231, 21000, Dijon, France.
8
FCS Bourgogne-Franche Comté, LipSTIC LabEx, 21000, Dijon, France.
PMID:
37468928
PMCID:
PMC10357707
DOI:
10.1186/s13054-023-04574-8
No abstract available
Publication types
Letter
MeSH terms
Cohort Studies
Humans
Retrospective Studies
Shock, Cardiogenic* / drug therapy
Vasopressins* / therapeutic use
Substances
Vasopressins